Pharmacogenomics for infectious diseases in sub-Saharan Africa: Successes and opportunities

The rate of mortality in developing countries due to communicable remains alarmingly high. The leading contributors to disease in these regions are the so-called “big three”, namely HIV/ , TB, and malaria. The global prevalence of these diseases is over 250 million, and it should be noted that 71%, 28% and 88% of these , respectively, occur in sub-Saharan Africa alone (World Health ). African countries are continuously struggling to contain diseases, and there is a need for governments to commit not only for treatment, but also towards research and aimed at innovative approaches.